|
July 2, 2020
|
Neoleukin Therapeutics Announces Pricing of $76.2 Million Public Offering
|
|
|
July 1, 2020
|
Neoleukin Therapeutics Announces Proposed Public Offering
|
|
|
June 22, 2020
|
Neoleukin Therapeutics Presents Preclinical Data for NL-201 and De Novo Protein Design Technology at American Association for Cancer Research (AACR) Virtual Annual Meeting II
|
|
|
June 15, 2020
|
Neoleukin Therapeutics to Host Investor R&D Showcase Highlighting De Novo Protein Therapeutics
|
|
|
June 1, 2020
|
Neoleukin Therapeutics Announces Appointment of Erin Lavelle to Board of Directors
|
|
|
May 27, 2020
|
Neoleukin Therapeutics to Present at Jefferies Virtual Healthcare Conference
|
|
|
May 15, 2020
|
Neoleukin Therapeutics Announces Multiple Presentations at American Association for Cancer Research (AACR) Virtual Annual Meeting II
|
|
|
May 7, 2020
|
Neoleukin Therapeutics to Present at Virtual BofA Securities 2020 Health Care Conference
|
|
|
May 6, 2020
|
Neoleukin Therapeutics Announces First Quarter 2020 Financial Results and Provides Business Update
|
|
|
April 16, 2020
|
Neoleukin Therapeutics Announces Change of Location of Annual Meeting of Stockholders to Be Held May 5, 2020
|
|
